您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (7): 6-10.doi: 10.6040/j.issn.1671-7554.0.2015.1247

• • 上一篇    下一篇

ARNT2在胃癌中的表达及临床意义

郝姝桦,郏雁飞,郑燕,马晓丽,孔毅,黎娉,宗帅,张垚,汪运山   

  1. 山东大学附属济南市中心医院中心实验室, 山东 济南 250013
  • 收稿日期:2015-12-07 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 汪运山. E-mail:sdjnwys@163.com E-mail:sdjnwys@163.com
  • 基金资助:
    国家自然科学基金(810008869,81272588);国家重点基础研究发展计划(973计划)(2012CB966503,2012CB966504);山东省自然科学基金(ZR2015HM018,ZR2012HM061);山东省优秀中青年科学家科研奖励基金(BS2011YY039)

Expression and clinical significance of ARNT2 in gastric carcinoma

HAO Shuhua, JIA Yanfei, ZHENG Yan, MA Xiaoli, KONG Yi, LI Ping, ZONG Shuai, ZHANG Yao, WANG Yunshan   

  1. Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Received:2015-12-07 Online:2016-07-10 Published:2016-07-10

PDF (PC)

261

摘要： 目的 探讨人胃癌中芳香烃受体核易位蛋白2(ARNT2)的表达及临床意义。 方法 运用qRT-PCR和Western blotting检测ARNT2在正常胃细胞株及多种胃癌细胞株中的表达。通过免疫组织化学检测61例胃癌组织及相应癌旁胃黏膜组织中ARNT2的表达。 结果 ARNT2 mRNA和蛋白在胃癌细胞株中的表达水平显著低于正常胃细胞株。胃癌组织中ARNT2的阳性表达率显著低于癌旁胃黏膜组织(32.79% vs 80.33%,P<0.05),与细胞株的检测结果一致。并且,胃癌中ARNT2的表达水平与肿瘤的分化程度显著相关(P<0.05)。 结论 ARNT2在胃癌细胞及组织中低表达,并且其表达水平与胃癌的分化程度相关,提示其可能参与胃癌的发生与发展。

关键词: 转录因子, 胃癌, 芳香烃受体核易位蛋白2

Abstract: Objective To investigate the expression of aryl hydrocarbon receptor nuclear translocator 2(ARNT2)in human gastric carcinoma and its clinical significance. Methods The mRNA and protein expression levels of ARNT2 in normal gastric cell line and several gastric cancer cell lines were measured by quantitative real-time reverse transcription-polymerase chain reaction(qRT-PCR)and Western blotting. The expressions of ARNT2 protein in 61 cases of gastric cancer tissues and adjacent non-tumor tissues were detected by immunohistochemistry. Results The mRNA and protein expressions of ARNT2 in gastric cancer cell lines were significantly lower than those in normal gastric cell line. The positive expression of ARNT2 in gastric cancer tissues was lower than that in adjacent non-tumor tissues(32.79% vs 80.33%, P<0.05). Furthermore, ARNT2 expression was closely correlated with the differentiation of gastric cancer(P<0.05). Conclusion The expression of ARNT2 is lower in gastric cancer cells and tissues than in non-tumor cells and tissues, and is correlated with the differentiation of gastric cancer, which suggests that ARNT2 may participate in the occurrence and development of gastric cancer.

Key words: Gastric carcinoma, Aryl hydrocarbon receptor nuclear translocator 2, Transcription factor

中图分类号: 

  • R735.2
[1] Bersten DC, Sullivan AE, Peet DJ, et al. bHLH-PAS proteins in cancer[J]. Nat Rev Cancer, 2013, 13(12): 827-841.
[2] Hirose K, Morita M, Ema M, et al. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor(Arnt2)with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator(Arnt)[J]. Mol Cell Biol, 1996, 16(4): 1706-1713.
[3] Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein(Arnt)as a component of the DNA binding form of the Ah receptor[J]. Science, 1992, 256(5060): 1193-1195.
[4] Drutel G, Kathmann M, Heron A, et al. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator(ARNT)[J]. Biochem Biophy Res Commun, 1996, 225(2): 333-339.
[5] Aitola MH, Pelto-Huikko MT. Expression of Arnt and Arnt2 mRNA in developing murine tissues[J]. J Histochem Cytochem, 2003, 51(1): 41-54.
[6] Hankinson O. Why does ARNT2 behave differently from ARNT?[J]. Toxicol Sci, 2008, 103(1): 1-3.
[7] Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315.
[8] Martinez V, Kennedy S, Doolan P, et al. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue[J]. Breast Cancer Res Treat, 2008, 110(3): 521-530.
[9] Yang B, Yang E, Liao H, et al. ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer[J]. Tumour Biol, 2015, 36(3): 2111-2119.
[10] Li W, Liang Y, Yang B, et al. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2015, 30(6): 1085-1093.
[11] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[12] 邹文斌, 李兆申. 中国胃癌发病率及死亡率研究进展[J]. 中国实用内科杂志, 2014, 34(4): 408-415.
[13] Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2(Arnt2)gene reveals partial redundancy with Arnt[J]. Proc Natl Acad Sci USA, 2001, 98(12): 6692-6697.
[14] Sribudiani Y, Metzger M, Osinga J, et al. Variants in RET associated with Hirschsprungs disease affect binding of transcription factors and gene expression[J]. Gastroenterology, 2011, 140(2): 572-582 e2. doi: 10.1053/j.gastro.2010.10.044.
[15] Zudaire E, Cuesta N, Murty V, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers[J]. J Clin Invest, 2008, 118(2): 640-650.
[16] Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315.
[17] Garritano S, Inga A, Gemignani F, et al. More targets, more pathways and more clues for mutant p53[J]. Oncogenesis, 2013, 2: e54. doi: 10.1038/oncsis.2013.15.
[1] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[2] 宗帅,肖东杰,刘华,郏雁飞,马晓丽,李焕杰,黎娉,郑燕,汪运山. CSN5在胃癌中的表达及与患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(7): 12-16.
[3] 李景媛,宋玲,林松,宋晖. 不同浓度一氧化碳释放分子-3对大鼠骨髓间充质干细胞成骨分化的影响[J]. 山东大学学报（医学版）, 2017, 55(7): 31-37.
[4] 孟繁超,冯鹭,邵广瑞. 人乳腺癌细胞系MCF-7中FOXM1调控SYK转录[J]. 山东大学学报（医学版）, 2017, 55(3): 19-24.
[5] 丁凤,董亚兵,赵华强,朱国雄,吴高义. 在慢性睡眠剥夺中骨桥蛋白通过NF-kappaB通路对颞下颌关节的影响[J]. 山东大学学报（医学版）, 2016, 54(9): 41-47.
[6] 董秀红. 认知催眠疗法减轻胃癌化疗患者癌因性疲乏的疗效观察[J]. 山东大学学报（医学版）, 2016, 54(7): 56-59.
[7] 马会明,张永芳,王蒙蒙,李昕,王永峰,田洪成,胡蓉,王燕蓉,裴秀英,徐仙. 雌激素对卵巢颗粒细胞雌激素受体-β和转录因子叉头蛋白3表达的影响[J]. 山东大学学报（医学版）, 2016, 54(5): 50-55.
[8] 张守彩,高玉,郑桂喜,杨咏梅,刘延红,高杨,王传新. 两种方法评估胃蛋白酶原在萎缩性胃炎和胃癌中的诊断价值[J]. 山东大学学报（医学版）, 2016, 54(12): 46-52.
[9] 李帅,李迪诺,袁超凡,梁旭,王玉彬. miR-98-5p靶向调控AKT2基因对人胃癌MGC803细胞增殖的影响[J]. 山东大学学报（医学版）, 2016, 54(11): 27-31.
[10] 赵璐, 孙俊波, 魏桂梅. MRP8通过NF-κB信号通路调控痛风细胞模型中IL-1β的表达[J]. 山东大学学报（医学版）, 2015, 53(6): 44-47.
[11] 韦丽兰, 莫书荣. 红景天苷对人胃癌细胞SGC-7901抑瘤作用的体外实验研究[J]. 山东大学学报（医学版）, 2015, 53(12): 12-15,32.
[12] 付海燕, 胡占升, 杜红阳. 白藜芦醇衍生物TMS对脂多糖诱导血管内皮细胞表达NO、ICAM-1和NF-κB的影响[J]. 山东大学学报（医学版）, 2015, 53(11): 10-15.
[13] 高鹏, 沈方臻, 肖文静, 修元德, 周玲玲. IB期非小细胞肺癌Runx2、Ezrin表达与术后转移的相关性[J]. 山东大学学报（医学版）, 2015, 53(1): 63-66.
[14] 朱丽华, 赵琳琳, 李盖. 靶向沉默IL-6R基因对胃癌细胞增殖的影响[J]. 山东大学学报（医学版）, 2014, 52(S1): 22-23.
[15] 徐光辉, 李玉, 刘忠伦, 胡楠. 晚期胃癌患者血清TP表达与含替吉奥方案化疗疗效的相关性研究[J]. 山东大学学报（医学版）, 2014, 52(S1): 77-79.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发